Details

Autor(en) / Beteiligte

• Liu, Hai-bo
• Xu, Bo
• Gao, Run-lin
• Yang, Yue-jin
• Yao, Min
• Qin, Xue-wen
• Wu, Yong-jian
• Yuan, Jin-qing
• Ma, Wei-hua
• Qiao, Shu-bin
• Chen, Ji-lin

Titel

Outcomes of using Firebird rapamycin eluting stents in routine coronary intervention practice： one-year results from the pilot study of Firebird in China registry

Ist Teil von

• Chinese medical journal, 2006-04, Vol.119 (7), p.609-611

Ort / Verlag

China: Cardiovascular Institute and Fuwai Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100037, China

Erscheinungsjahr

2006

Quelle

Free E-Journal (出版社公開部分のみ）

Beschreibungen/Notizen

• Recent clinical trials with rapamycin-eluting stents ,have shown very low restenosis rates.However, the higher penetration of drug eluting stent （DES） in China is being limited by the high costs of these imported devices, especially when considering multiple stenting. Firebird （Microport Co. Ltd., China） is a rapamycin （Huadong Pharmaceutical, China） polymer-based eluting stent with reasonable cost. The objective of this study was to evaluate the safety and efficacy of using Firebird stents in routine interventional practice.